Variant report

Variant	nsv519502
Chromosome Location	chr12:1314430-1366511
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:292)
CpG islands
(count:306)
Chromatin interactive
region (count:16)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:292 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr12:1335695-1335957	GM12878	blood:	n/a	n/a
2	BATF	chr12:1335617-1335994	GM12878	blood:	n/a	n/a
3	BATF	chr12:1336135-1336446	GM12878	blood:	n/a	chr12:1336325-1336336
4	BATF	chr12:1336172-1336455	GM12878	blood:	n/a	chr12:1336325-1336336
5	BRCA1	chr12:1326108-1327006	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr12:1326280-1326651	IMR90	lung:	n/a	n/a
7	CEBPB	chr12:1326237-1326703	MCF-7	breast:	n/a	n/a
8	CEBPB	chr12:1326297-1326684	MCF-7	breast:	n/a	n/a
9	CEBPB	chr12:1327544-1327921	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr12:1327636-1327849	HepG2	liver:	n/a	n/a
11	CEBPB	chr12:1324913-1325149	HepG2	liver:	n/a	n/a
12	CEBPB	chr12:1326215-1327174	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr12:1324865-1325159	IMR90	lung:	n/a	n/a
14	CEBPB	chr12:1355868-1356196	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr12:1355879-1356175	K562	blood:	n/a	n/a
16	CEBPB	chr12:1324819-1325149	Hela-S3	cervix:	n/a	n/a
17	CEBPB	chr12:1355759-1356204	HCT-116	colon:	n/a	n/a
18	CEBPB	chr12:1317917-1318120	K562	blood:	n/a	n/a
19	CHD2	chr12:1326226-1327060	Hela-S3	cervix:	n/a	n/a
20	CTCF	chr12:1322866-1322903	GM10248	blood:	n/a	n/a
21	CTCF	chr12:1357080-1357230	A549	lung:	n/a	n/a
22	E2F4	chr12:1326131-1326520	MCF10A-Er-Src	breast:	n/a	n/a
23	E2F4	chr12:1314768-1314968	MCF10A-Er-Src	breast:	n/a	n/a
24	E2F4	chr12:1331989-1332189	MCF10A-Er-Src	breast:	n/a	n/a
25	E2F4	chr12:1330925-1331253	MCF10A-Er-Src	breast:	n/a	n/a
26	EBF1	chr12:1335809-1335822	GM12878	blood:	n/a	n/a
27	EBF1	chr12:1348941-1349156	GM12878	blood:	n/a	chr12:1349050-1349061
28	EBF1	chr12:1348914-1349234	GM12878	blood:	n/a	chr12:1349050-1349061
29	EP300	chr12:1360535-1362598	SK-N-SH	brain:	n/a	chr12:1360535-1360549
30	EP300	chr12:1336143-1336416	SK-N-SH_RA	brain:	n/a	n/a
31	EP300	chr12:1359097-1359381	SK-N-SH_RA	brain:	n/a	n/a
32	EP300	chr12:1355811-1356214	SK-N-SH_RA	brain:	n/a	n/a
33	EP300	chr12:1343295-1343553	SK-N-SH_RA	brain:	n/a	n/a
34	EP300	chr12:1359657-1360174	SK-N-SH_RA	brain:	n/a	n/a
35	EP300	chr12:1325936-1327142	Hela-S3	cervix:	n/a	chr12:1326454-1326461
36	EP300	chr12:1355858-1356194	K562	blood:	n/a	n/a
37	EP300	chr12:1325967-1327010	SK-N-SH	brain:	n/a	chr12:1326454-1326461
38	EP300	chr12:1361764-1362445	SK-N-SH_RA	brain:	n/a	n/a
39	EP300	chr12:1327589-1327873	Hela-S3	cervix:	n/a	n/a
40	EP300	chr12:1359059-1359336	SK-N-SH_RA	brain:	n/a	n/a
41	EP300	chr12:1355645-1356354	SK-N-SH	brain:	n/a	n/a
42	EP300	chr12:1325906-1327083	SK-N-SH	brain:	n/a	chr12:1326454-1326461
43	EP300	chr12:1361751-1362501	SK-N-SH_RA	brain:	n/a	n/a
44	EP300	chr12:1326022-1327311	SK-N-SH_RA	brain:	n/a	chr12:1326454-1326461
45	EP300	chr12:1355787-1356182	SK-N-SH_RA	brain:	n/a	n/a
46	EP300	chr12:1332867-1333249	SK-N-SH_RA	brain:	n/a	n/a
47	EP300	chr12:1325203-1327567	SK-N-SH	brain:	n/a	chr12:1326454-1326461
48	EP300	chr12:1326097-1327372	SK-N-SH_RA	brain:	n/a	chr12:1326454-1326461
49	EP300	chr12:1359768-1360152	SK-N-SH_RA	brain:	n/a	n/a
50	FOS	chr12:1314825-1315469	HUVEC	blood vessel:	n/a	chr12:1314995-1315005 chr12:1314996-1315004 chr12:1314994-1315006 chr12:1314995-1315005 chr12:1314994-1315005

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1327264-1327314	HRCEpiC	kidney:	n/a
2	chr12:1327264-1327314	HRCEpiC	kidney:	n/a
3	chr12:1351149-1351199	A549	lung:	n/a
4	chr12:1352875-1352925	Hepatocyte	liver:	n/a
5	chr12:1327264-1327314	CMK	blood:	n/a
6	chr12:1327264-1327314	HRE	kidney:	n/a
7	chr12:1352926-1352976	AG04449	skin:	fetal
8	chr12:1327264-1327314	MCF10A-Er-Src	breast:	n/a
9	chr12:1352926-1352976	NH-A	brain:	n/a
10	chr12:1352926-1352976	PANC-1	pancreas:	n/a
11	chr12:1327264-1327314	BE2_C	brain:	n/a
12	chr12:1352926-1352976	HCM	heart:	n/a
13	chr12:1351149-1351199	SAEC	small airway:	n/a
14	chr12:1352875-1352925	CMK	blood:	n/a
15	chr12:1352926-1352976	NHDF-neo	bronchial:	n/a
16	chr12:1352926-1352976	BE2_C	brain:	n/a
17	chr12:1327264-1327314	HNPCEpiC	eye:	n/a
18	chr12:1352926-1352976	NT2-D1	testis:	n/a
19	chr12:1327264-1327314	MCF-7	breast:	n/a
20	chr12:1352911-1352961	HCM	heart:	n/a
21	chr12:1327264-1327314	HPAEpiC	pulmonary alveolar:	n/a
22	chr12:1352875-1352925	HRE	kidney:	n/a
23	chr12:1352911-1352961	AoSMC	blood vessel:	n/a
24	chr12:1351149-1351199	ECC-1	luminal epithelium:	n/a
25	chr12:1352875-1352925	HEEpiC	esophagus:	n/a
26	chr12:1352875-1352925	HMEC	breast:	n/a
27	chr12:1352875-1352925	Jurkat	blood:	n/a
28	chr12:1351149-1351199	HRE	kidney:	n/a
29	chr12:1327264-1327314	SKMC	muscle:	n/a
30	chr12:1352875-1352925	HAEpiC	amniotic membrane:	n/a
31	chr12:1352875-1352925	BJ	skin:	n/a
32	chr12:1352875-1352925	HEK293	kidney:	embryo
33	chr12:1351149-1351199	GM06990	blood:	n/a
34	chr12:1352875-1352925	NHDF-neo	bronchial:	n/a
35	chr12:1352911-1352961	IMR90	lung:	fetal
36	chr12:1327264-1327314	GM06990	blood:	n/a
37	chr12:1352926-1352976	ECC-1	luminal epithelium:	n/a
38	chr12:1352911-1352961	Hela-S3	cervix:	n/a
39	chr12:1352926-1352976	NHBE	bronchial:	n/a
40	chr12:1351149-1351199	ProgFib	skin:	n/a
41	chr12:1352926-1352976	LNCaP	prostate:	n/a
42	chr12:1352875-1352925	GM19239	blood:	n/a
43	chr12:1352926-1352976	Hepatocyte	liver:	n/a
44	chr12:1352875-1352925	MCF10A-Er-Src	breast:	n/a
45	chr12:1351149-1351199	HEEpiC	esophagus:	n/a
46	chr12:1352926-1352976	T-47D	breast:	n/a
47	chr12:1351149-1351199	NT2-D1	testis:	n/a
48	chr12:1352926-1352976	AG09319	gingival:	n/a
49	chr12:1352911-1352961	T-47D	breast:	n/a
50	chr12:1352911-1352961	K562	blood:	n/a

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:1316163..1318272-chr12:1321850..1324062,2	MCF-7	breast:
2	chr12:1316163..1318272-chr12:1321850..1324062,2	MCF-7	breast:
3	chr12:1350007..1350508-chr6:80690705..80691205,2	Hela-S3	cervix:
4	chr12:1335548..1337986-chr12:1340753..1343719,2	K562	blood:
5	chr12:1323691..1326096-chr12:1328110..1330887,3	K562	blood:
6	chr12:1345086..1347706-chr12:1348677..1351190,2	K562	blood:
7	chr12:1323691..1326096-chr12:1328110..1330887,3	K562	blood:
8	chr12:1345086..1347706-chr12:1348677..1351190,2	K562	blood:
9	chr12:1357106..1358885-chr12:1361378..1363992,2	MCF-7	breast:
10	chr12:1343229..1344970-chr12:1348640..1350399,2	K562	blood:
11	chr12:1322894..1325087-chr12:1546213..1548025,2	K562	blood:
12	chr12:1360740..1362305-chr12:1366547..1369167,2	K562	blood:
13	chr12:1357106..1358885-chr12:1361378..1363992,2	MCF-7	breast:
14	chr12:1343229..1344970-chr12:1348640..1350399,2	K562	blood:
15	chr12:1299686..1301198-chr12:1315494..1317236,2	K562	blood:
16	chr12:1335548..1337986-chr12:1340753..1343719,2	K562	blood:

No data

Variant related genes	Relation type
ERC1	TF binding region
ERC1	CpG island

Extended variants
information (count: 1990 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:1990 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2189788	chr12:1314430-1314431	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs545760690	chr12:1314442-1314443	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs544711202	chr12:1314472-1314473	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs565414902	chr12:1314533-1314534	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs193281885	chr12:1314545-1314546	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs201203826	chr12:1314547-1314548	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs566338259	chr12:1314559-1314560	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs551630470	chr12:1314564-1314565	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs58629430	chr12:1314580-1314581	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs2189787	chr12:1314581-1314582	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs567328687	chr12:1314583-1314584	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs529551836	chr12:1314682-1314683	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs115044955	chr12:1314684-1314685	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs540495303	chr12:1314765-1314766	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs144950154	chr12:1314768-1314769	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs569484440	chr12:1314802-1314803	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs540142923	chr12:1314813-1314814	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs185544115	chr12:1314960-1314961	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs190405346	chr12:1314984-1314985	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs181754374	chr12:1314990-1314991	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs114728390	chr12:1314994-1314995	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs185750841	chr12:1315062-1315063	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs61914328	chr12:1315114-1315115	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs539842480	chr12:1315122-1315123	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs188601488	chr12:1315123-1315124	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs181140845	chr12:1315140-1315141	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs553903053	chr12:1315142-1315143	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs560441533	chr12:1315206-1315207	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs76957359	chr12:1315211-1315212	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs139550278	chr12:1315216-1315217	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs561012008	chr12:1315252-1315253	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs531419162	chr12:1315274-1315275	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs549577765	chr12:1315284-1315285	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs116558193	chr12:1315311-1315312	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs533318563	chr12:1315326-1315327	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs115955939	chr12:1315335-1315336	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs142771246	chr12:1315338-1315339	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs151021920	chr12:1315359-1315360	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs548942077	chr12:1315380-1315381	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs113879148	chr12:1315406-1315407	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs545788465	chr12:1315417-1315418	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs139615366	chr12:1315421-1315422	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs190759988	chr12:1315463-1315464	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs577769478	chr12:1315510-1315511	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs149733996	chr12:1315511-1315512	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs75177212	chr12:1315556-1315557	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs572367007	chr12:1315647-1315648	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs543684451	chr12:1315747-1315748	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs560883265	chr12:1315788-1315789	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs78821868	chr12:1315841-1315842	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Cancer	17440070	CNVD
Autism	22495311	CNVD
Pancreatic cancer	17952125	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
small cell lung cancer	20016488	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:844 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1241800-1326600	Weak transcription	Pancreas	Pancrea
2	chr12:1283800-1315200	Weak transcription	HSMMtube	muscle
3	chr12:1306800-1316000	Weak transcription	Fetal Brain Female	brain
4	chr12:1308200-1326000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr12:1308200-1329800	Weak transcription	Fetal Muscle Trunk	muscle
6	chr12:1308400-1324200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr12:1308600-1321600	Weak transcription	Fetal Intestine Small	intestine
8	chr12:1308600-1326000	Weak transcription	A549	lung
9	chr12:1308600-1329800	Weak transcription	Fetal Intestine Large	intestine
10	chr12:1312400-1320400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr12:1312800-1315200	Active TSS	Stomach Smooth Muscle	stomach
12	chr12:1312800-1315800	Active TSS	Right Atrium	heart
13	chr12:1313000-1315400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
14	chr12:1313400-1314600	Active TSS	Primary T regulatory cells fromperipheralblood	blood
15	chr12:1313400-1314600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr12:1313400-1314800	Flanking Active TSS	HUVEC	blood vessel
17	chr12:1313600-1314600	Active TSS	Rectal Mucosa Donor 29	rectum
18	chr12:1313600-1315000	Enhancers	ES-I3 Cell Line	embryonic stem cell
19	chr12:1313600-1315200	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr12:1313800-1314600	Active TSS	Primary T helper cells fromperipheralblood	blood
21	chr12:1313800-1314600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr12:1313800-1314800	Active TSS	Primary T helper memory cells from peripheral blood 1	blood
23	chr12:1313800-1315000	Active TSS	Pancreatic Islets	Pancreatic Islet
24	chr12:1314000-1315000	Active TSS	Rectal Smooth Muscle	rectum
25	chr12:1314200-1314800	Weak transcription	Brain Anterior Caudate	brain
26	chr12:1314200-1315200	Weak transcription	Hela-S3	cervix
27	chr12:1314200-1315600	Enhancers	Duodenum Mucosa	Duodenum
28	chr12:1314200-1319000	Weak transcription	Stomach Mucosa	stomach
29	chr12:1314200-1320400	Weak transcription	Placenta	Placenta
30	chr12:1314200-1320600	Weak transcription	Small Intestine	intestine
31	chr12:1314200-1321400	Weak transcription	Left Ventricle	heart
32	chr12:1314200-1326000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
33	chr12:1314200-1326400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr12:1314200-1326600	Weak transcription	Esophagus	oesophagus
35	chr12:1314200-1329000	Weak transcription	Brain Cingulate Gyrus	brain
36	chr12:1314400-1314600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr12:1314400-1314600	Flanking Active TSS	Primary B cells from cord blood	blood
38	chr12:1314400-1314600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
39	chr12:1314400-1314600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
40	chr12:1314400-1314600	Weak transcription	Primary T helper cells PMA-I stimulated	--
41	chr12:1314400-1314600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
42	chr12:1314400-1314600	Weak transcription	Adipose Nuclei	Adipose
43	chr12:1314400-1314600	Enhancers	Dnd41	blood
44	chr12:1314400-1314800	Active TSS	iPS-20b Cell Line	embryonic stem cell
45	chr12:1314400-1314800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
46	chr12:1314400-1314800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
47	chr12:1314400-1314800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
48	chr12:1314400-1314800	Enhancers	Fetal Heart	heart
49	chr12:1314400-1314800	Weak transcription	K562	blood
50	chr12:1314400-1315000	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links